New combo treatment tackles heel pain that Won't go away
NCT ID NCT05622279
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested a procedure that combines a needle tenotomy (breaking up scar tissue with a needle) with an injection of platelet-rich plasma (PRP) for people with chronic plantar fasciitis that didn't improve with standard treatments like physical therapy or steroid shots. Nineteen adults with heel pain lasting over 3 months took part. The goal was to see if the treatment reduces pain and is safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
platelet-rich plasma (PRP) injection
What this could lead to
If it works, this could offer a new treatment option for people with stubborn plantar fasciitis that hasn't improved with standard care.
What could go wrong
This is a very small pilot study with only 19 people and no comparison group. Results may not apply to everyone, and the procedure itself can be painful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLANTAR FASCITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nantes
Nantes, France, 44000, France